Post-approval studies (Phase 4)Looking for participantsNCT06562582What this trial is testingSTunning in Acute Myocardial Infarction - BASWho this might be right forMyocardial Infarct Vastra Gotaland Region 120
Testing effectiveness (Phase 2)UnknownNCT06341842What this trial is testingPotential Protective Role of SGLT-2 Inhibitors for Chemotherapy-induced CardiotoxicityWho this might be right forBreast Cancer Fondazione IRCCS Policlinico San Matteo di Pavia 316
Post-approval studies (Phase 4)UnknownNCT02528019What this trial is testingMetabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) InhibitorsWho this might be right forEffects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic Complications Kurume University 100
Post-approval studies (Phase 4)UnknownNCT03573102What this trial is testingEffect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic PatientsWho this might be right forDiabetic Nephropathies Nahla H Tohami 60
Not applicableStudy completedNCT03717207What this trial is testingCardiac Autonomic Dysfunction in Diabetics Patients With SyncopeWho this might be right forSyncope, Vasovagal University of Campania Luigi Vanvitelli 242
Not applicableNot Yet RecruitingNCT06668753What this trial is testingEffect of SGLT2 Inhibitors on NAFLD in Type 2 Diabetic Patients with Diabetic NephropathyWho this might be right forEffect of SGLT2 Inhibitors NAFLD in Type 2 Diabetic Patients with Diabetic Nephropathy Assiut University 114
Not applicableLooking for participantsNCT06283420What this trial is testingMetabolic Response to the Initiation of Heart Failure TherapyWho this might be right forHeart Failure Vojtech Melenovsky, MD, PhD 120
Testing effectiveness (Phase 2)Study completedNCT03922750What this trial is testingA Research Study in People With Type 2 Diabetes to Compare Two Types of Insulin: Insulin 287 and Insulin GlargineWho this might be right forDiabetes Mellitus, Type 2 Novo Nordisk A/S 154
Not applicableStudy completedNCT06797115What this trial is testingHydroxyl Free Radical Associated Effects of SGLT-2 Inhibitors in Type 2 DiabetesWho this might be right forT2DM University of Pecs 40
Post-approval studies (Phase 4)Not Yet RecruitingNCT07351864What this trial is testingFinerenone Plus SGLT2 Inhibitors in Heart FailureWho this might be right forHeart Failure Mansoura University 60
Not applicableUnknownNCT06128096What this trial is testingThe Effect of SGLT-2 Inhibitors on Epicardial Adipose Tissue and Cardiac Function in T2DM Patients With CAD (EpiCAD)Who this might be right forCoronary Artery Disease Clinical Research Centre, Malaysia 360
Not applicableStudy completedNCT05640180What this trial is testingAn Observational Study Called FLAMINgO to Learn More About the Treatment Combination of Finerenone and SGLT2 Inhibitors in People With Long-term Kidney Disease (Chronic Kidney Disease) Together With Type 2 Diabetes by Using Routine Medical Care Data and Past Clinical Study ResultsWho this might be right forChronic Kidney DiseaseType 2 Diabetes Bayer 17,847
Not applicableUnknownNCT05477017What this trial is testingEvaluation of SGLT2-i Effectivness and Safety in Elderly Type 2 Diabetes PatientsWho this might be right forType2Diabetes University of Milan 800
Testing effectiveness (Phase 2)Study completedNCT07610174What this trial is testingEffects of Dapagliflozin, Semaglutide, and Their Combination in Heart Failure Patients With Prosthetic Heart ValvesWho this might be right forHeart FailureHeart Valve Prosthesis Kafrelsheikh University 160
Large-scale testing (Phase 3)Study completedNCT07591077What this trial is testingSGLT2 Adjunct in T1DWho this might be right forType 1 DiabetesNephropathy, Diabetic Ain Shams University 86
Not applicableStudy completedNCT02636192What this trial is testingStudy on Incidence of Diabetic Ketoacidosis Among Participants With Type 2 Diabetes Mellitus Treated With Sodium-glucose Co-transporter 2 (SGLT2) Inhibitors or Other Antihyperglycemic AgentsWho this might be right forDiabetes Mellitus, Type 2 Janssen Research & Development, LLC 200,000
Large-scale testing (Phase 3)Looking for participantsNCT07214818What this trial is testingSGLT2 Inhibitors in Adult Primary Nephrotic SyndromeWho this might be right forNephrotic Syndrome Mansoura University 75
Post-approval studies (Phase 4)UnknownNCT04796428What this trial is testingGliflOzin in eLderly Diabetic patiENts: A praGmatic Intraclass Evaluation TrialWho this might be right forDiabetes Mellitus, Type 2 Center for Outcomes Research and Clinical Epidemiology, Italy 1,167
Large-scale testing (Phase 3)Study completedNCT05283057What this trial is testingEmpagliflozin in Patients With GlomerulonephritisWho this might be right forGlomerulonephritisProteinuria Kasr El Aini Hospital 50
Post-approval studies (Phase 4)Not Yet RecruitingNCT07537088What this trial is testingEfficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney DiseaseWho this might be right forT2DM (Type 2 Diabetes Mellitus)CKD - Chronic Kidney Disease First Affiliated Hospital of Wannan Medical College 468